Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate restores federal 340B pharmacy access to neighborhood pharmacies in House Bill 23 85
Summary
The Oregon Senate passed House Bill 23 85 to prohibit drug manufacturers from restricting where 340B-covered entities can have outpatient prescriptions filled, restoring broader contract-pharmacy access and prompting competing arguments about transparency, hospital finances and patient benefit.
The Oregon Senate on the final reading passed House Bill 23 85, a measure aimed at restoring how the federal 340B drug-pricing program operates for hospitals and federally qualified health centers in the state.
Senator Patterson, the bill’s carrier, told colleagues the 340B program "is a federal program that provides significant discounts on prescription drugs to eligible health care organizations serving low income patients" and that House Bill 23 85 "simply restores the program to its previous version by prohibiting drug manufacturers from restricting these entities' access to the 340B program." The bill passed after senators defeated a motion to substitute a minority report that would have added transparency and reporting requirements.
Why it matters: Supporters say reversing manufacturer-imposed limits will protect access to discounted outpatient drugs for safety-net providers and the communities they serve. Opponents argue the bill leaves unresolved how 340B savings are used, saying the program has grown…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
